Cite
HARVARD Citation
Webb, D. et al. (2020). A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes. Diabetes, obesity & metabolism. 22 (7), pp. 1187-1196. [Online].